Impact of the COVID-19 Pandemic on Laboratory Services

Yani Triyani, Rita Herawati, Rahmawati Rahmawati, Ranti Permatasari

Abstract


The positive impact of the coronavirus disease 2019 (COVID-19) pandemic is that hospital laboratory services are excellent when other services are declining. Aside from molecular biology laboratory (polymerase chain reaction, PCR) services for COVID-19 diagnostics, public demand has dramatically increased. It is a retrospective descriptive study that uses data on the total number and types of results of laboratory examination orders that have been verified from the laboratory information system of a hospital from 2018 to 2022. Data analysis is presented in the frequency of the number and type of results of laboratory examination orders and differences in requests for laboratory services before and during the pandemic since the government established it on March 8, 2020. The total number of laboratory requests between January 2018 and December 2022 was 1,943,539 services. The highest increase in laboratory examination services was in molecular biology (98.4%). As the need for community services increases for the PCR severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) examination, which is used in addition to diagnosing confirmed COVID-19 patients, it is also necessary for the community to conduct tracing if a family member has a COVID infection or travel requirements and follow-up for hospital employee exit tests who contracted COVID-19. In conclusion, the COVID-19 pandemic has positively impacted laboratory performance. There have been changes and an increase in the number and types of laboratory examination services and personal performance and management in laboratories.


Keywords


Biology molecular test; COVID-19 pandemic; laboratory services; PCR SARS-CoV-2

Full Text:

PDF

References


Luo YT, Wang JH, Zhang MM, Wang QZ, Chen R, Wang XL, et al. COVID-19-another influential event impacts on laboratory medicine management. J Clin Lab Anal. 2021;35(6):e23804.

Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy and Clin Immunol. 2020;146(3):518–34.e1.

Vatansever HS, Becer E. Relationship between IL-6 and COVID-19: To be considered during treatment. Future Virol. 2020;15(12):817–22.

Tandara L, Filipi P, Supe Domic D, Kresic B, Ivcic I, Stipic SS, et al. Laboratory medicine in pandemic of COVID-19. Biochem Med (Zagreb). 2022;32(2):020501.

Durant TJS, Peaper DR, Ferguson D, Schulz WL. Impact of COVID-19 pandemic on laboratory utilization. J Appl Lab Med. 2020;5(6):1194–205.

Dunbar S, Babady E, Das S, Moore C. Editorial: impact of COVID-19 on the clinical microbiology laboratory: preparing for the next pandemic. Front Cell Infect Microbiol. 2022;12:1031436.

Aisyah DN, Mayadewi CA, Igusti G, Manikam L, Adisasmito W, Kozlakidis Z. Laboratory readiness and response for SARS-CoV-2 in Indonesia. Front Public Health. 2021;9:705031.

Pritzker K. Impact of the COVID-19 pandemic on molecular diagnostics. Expert Rev Mol Diagn. 2021;21(6):519–21.

Bevins NJ, Luevano DR, Nuspl R, Wang-Rodriguez J. Test volume ratio benchmarking to identify and reduce low-value laboratory utilization. Am J Clin Pathol. 2021;156(4):708–14.

Zhang YY, Li BR, Ning BT. The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections. Front Immunol. 2020;11:2033.

Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122–7.

Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66–70.

Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: mechanisms underlying disease severity and progression. Physiology (Bethesda). 2020;35(5):288–301.

Mélo Silva Júnior ML, Souza LMA, Dutra REMC, Valente RGM, Melo TS. Review on therapeutic targets for COVID-19: Insights from cytokine storm. Postgrad Med J. 2021;97(1148):391–8.

Endo K, Miki T, Itoh T, Kubo H, Ito R, Ohno K, et al. Impact of the COVID-19 pandemic on glycemic control and blood pressure control in patients with diabetes in Japan. Intern Med. 2022;61(1):37–48.

Cromer SJ, Colling C, Schatoff D, Leary M, Stamou MI, Selen DJ, et al. Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: associated factors, short-term outcomes, and long-term glycemic phenotypes. J Diabetes Complications.

Ruissen MM, Regeer H, Landstra CP, Schroijen M, Jazet I, Nijhoff MF, et al. Increased stress, weight gain, and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care. 2021;9(1):e002035.

Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120.




DOI: https://doi.org/10.29313/gmhc.v11i3.12223

pISSN 2301-9123 | eISSN 2460-5441


Visitor since 19 October 2016: 


Free counters!


Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.